Treatment of the Overactive Bladder Syndrome: A Delphi Study

Status Completed

Clinical Trial Summary

Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high. Even guidelines are not always clear on the treatment management of drug therapy resistant OAB. Standardization in OAB treatment is needed.

Clinical Trial Description

Guidelines on the overactive bladder syndrome (European Association of Urology, American Urology Association and International Consultation on Incontinence) are comparable but remain vague mainly on the level between conservative and major surgery. They do not specify combinations of medications and do not distinguish between intradetrusor botulinum toxin injections (BTX) and sacral neuromodulation (SNM) because of lack of evidence. To reduce the variability in the treatment management of OAB, standardization is needed. By use of a Delphi technique, the current perception of Belgian urologists towards the most appropriate treatment approach for idiopathic OAB (iOAB) was explored. Based on these results a practical treatment algorithm for its use in daily clinical practice could be developed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04300400
Study type	Observational
Source	University Hospital, Ghent
Contact
Status	Completed
Phase
Start date	October 16, 2018
Completion date	September 10, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02540707` - Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes	Phase 4
Not yet recruiting	`NCT05977634` - Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder	N/A
Completed	`NCT01114412` - Basic Sensations Coming From the Bladder
Recruiting	`NCT06045728` - Telerehabilitation for Overactive Bladder Syndrome in Obese Women	N/A
Recruiting	`NCT03952299` - Oxybutynin for Post-surgical Bladder Pain and Urgency	Phase 3
Active, not recruiting	`NCT03758235` - Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin	Phase 3
Completed	`NCT01912885` - Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome	N/A
Recruiting	`NCT04982120` - Use of Repris Needle in Bladder Injection	N/A
Completed	`NCT06123364` - Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder	N/A
Recruiting	`NCT06088394` - Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder	N/A
Recruiting	`NCT05221021` - Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome	Phase 4
Terminated	`NCT04256876` - TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)	N/A
Not yet recruiting	`NCT03331081` - Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome	N/A
Recruiting	`NCT04873037` - BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder	N/A
Completed	`NCT02024945` - Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome	Phase 4
Completed	`NCT00546637` - Fesoterodine "add-on" Male Overactive Bladder Study	Phase 3
Not yet recruiting	`NCT06143397` - Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.	N/A
Recruiting	`NCT03044912` - Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan	Phase 3
Recruiting	`NCT03817203` - Effects of Kinesio Taping Application in Women With Overactive Bladder	N/A
Enrolling by invitation	`NCT06283498` - Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder	N/A